That's another box ticked.While this announcement is classified as non-price sensitive, it should not be overlooked since in August,Thr US Food and Drug Administration announced its intention to use ISO 13485 as the basis for its quality system legislation.Actually ISO 13485 has been operated by Australia,Brazil ,Canada,Japan and the USA as the foundation for the Medical Devices Single Audit Program. That's a great setpstone for our MEMS business expansion.
I also noticed that in the end of this announcement there is another our customer MiniFAB named.I think it is the first time we know MiniFAB is our customer.After browse their website it is said they have completed over 900 projects with clients worldwide.It is interesting to find that they are "currently developing and manufacturing customised microfluidic solutions for its global clients in the area of point of care diagnostic,lab- on-chip microfluidics and medical devices.""Projects include immuno and protein diagnostic for point of care applications;sample to answer molecular diagnostics for point of care applications,sample preparation modules for cell/bead applications;Smart implants for medical devices." There are a lot of potential to work together.
SE1 Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held